Skip to main content

Clinical trials

  • JNT517-301

    The goal of this Phase 3, randomized study is to assess the safety, efficacy, tolerability, and pharmacokinetics (PK) of oral JNT-517 in adults (18 years of age or older) with PKU. Participants will receive either JNT-517 or placebo and will be…

    Investigator
    Roberto T Zori
    Ages
    18 Years - N/A
    Sexes
    All
  • JNT517-501 Extension study

    The goal of this Phase 3, open-label study is to evaluate the long-term safety of JNT-517 in pediatric and adult participants with Phenylketonuria (PKU) after completion of either Study JNT517-101 (NCT05781399) or JNT517-201 (NCT06637514) as well as…

    Investigator
    Roberto T Zori
    Ages
    4 Years - N/A
    Sexes
    All